Latest News of BCRX
BioCryst Pharmaceuticals Inc (BCRX) Q3 2024 Earnings Call Highlights: Strong ORLADEYO Growth ...
By Yahoo! Finance |
2 weeks ago
Helen Thackray aims to demonstrate the effectiveness of Netherton syndrome treatment by focusing on skin penetration, target binding, and functional cure potential. Charlie Gayer expects continued ORL...
BioCryst Pharmaceuticals (BCRX) Q3 2024 Earnings Call Transcript
By Yahoo! Finance |
2 weeks ago
BioCryst Pharmaceuticals provided insights in their Q3 2024 earnings call. The company emphasized continued growth in Orladeyo revenue and confidence in reaching sustainable profitability. They discus...
Is BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) The Top Stock With Improving Technical Ratings According To Piper Sandler?
By Yahoo! Finance |
1 month ago
Piper Sandler's Top Technical Stock Picks include BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) ranking 14th. Recent market swings were influenced by economic data, geopolitical tensions, and job repor...